Figure 4. Associations of Different Pharmacotherapies and Risk of Death Over the 15-Year Follow-Up.

A, Patients predicted to die (5858 [29.3%] in the whole sample). B, Patients predicted to survive (14 142 [70.7%]). Analyses were stratified based on the out-of-training predictions in the discovery sample (n = 20 000). Antipsychotics were oral except for any long-acting injectable (LAI), which includes all LAI antipsychotics. Polypharmacy refers to concomitant use of 2 or more antipsychotics. HR indicates hazard ratio.